ESR1 and lung carcinoma: A 2008 study observed that the use of real-time PCR to assess the methylation of the ESR1 promoter in the blood proved very useful for the diagnosis of lung cancer, as these methylated genes might become crucial biomarkers for the early detection of lung cancer.